Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy

This study has been withdrawn prior to enrollment.
(Study pulled due to a grant disagreement between the U of M and SMDC)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00377091
First received: September 13, 2006
Last updated: May 28, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)